ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

NIEHS Conference to Look At 21st Century Issues

April 1, 1988

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

Chronobiology Review Still Delayed

May 5, 1989

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996